Item 9 Labs (INLB) Stock Price, News & Analysis

Company Overview

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 13.46 million shs
• Market Capitalization: $70,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

INLB Stock Analysis - Frequently Asked Questions

How were Item 9 Labs' earnings last quarter?

Item 9 Labs Corp. (OTC:INLB) announced its quarterly earnings results on Monday, May, 16th. The company reported ($0.04) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01.

How do I buy shares of Item 9 Labs?

Shares of INLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 5/16/2022
• Today: 9/20/2024
• Fiscal Year End: 9/30/2024

Industry, Sector and Symbol

• Stock Exchange: OTC
• Sector: Medical
• Industry: Dental equipment & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: OTC:INLB
• CUSIP: N/A
• CIK: N/A
• Web: www.item9labscorp.com
• Phone: 833-867-6337
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $21.76 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.65 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 701,919,000
• Free Float: 562,848,000
• Market Cap: $70,000.00
• Optionable: Not Optionable
• Beta: 0.77